Park Ki Hoon, Kwon Soon Seog, Chung Myung Hee, Kim Jeana, Lee Hee Jung, Min Ji-Won, Kim Yong Hyun
Department of Internal Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea School of Medicine, Bucheon, Korea.
Tuberc Respir Dis (Seoul). 2012 Aug;73(2):115-21. doi: 10.4046/trd.2012.73.2.115. Epub 2012 Aug 31.
Pulmonary mucosa-associated lymphoid tissue-derived (MALT) lymphoma is a rare disease. This disorder is considered to be a model of antigen-driven lymphoma, which is driven either by autoantigens or by chronic inflammatory conditions. Low-grade B-cell MALT lymphoma may develop from a nonneoplastic pulmonary lymphoproliferative disorder, such as lymphocytic interstitial pneumonitis (LIP). A recent estimate predicts that less than 5% of LIP patients acquire malignant, low-grade, B-cell lymphoma. In Korea, there has been no previous report of malignant low-grade, B-cell lymphoma, acquired from LIP. Here, we present the case of a patient with LIP that developed into pulmonary MALT lymphoma, six years after diagnosis.
肺黏膜相关淋巴组织来源(MALT)淋巴瘤是一种罕见疾病。这种疾病被认为是抗原驱动型淋巴瘤的一种模式,其由自身抗原或慢性炎症状态驱动。低度B细胞MALT淋巴瘤可能由非肿瘤性肺淋巴增殖性疾病发展而来,如淋巴细胞间质性肺炎(LIP)。最近的一项估计预测,不到5%的LIP患者会发展为恶性低度B细胞淋巴瘤。在韩国,此前尚无从LIP发展而来的恶性低度B细胞淋巴瘤的报道。在此,我们报告一例LIP患者在诊断六年后发展为肺MALT淋巴瘤的病例。